Home › Companies › ZEVRA THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ZEVRA THERAPEUTICS INC.’s Form 8-K, filed May 13, 2024 (Item 5.07 on EDGAR). Page generated November 1, 2026.
Meeting of May 13, 2024: 6 items on ZEVRA THERAPEUTICS INC.’s Form 8-K, filed May 13, 2024: 6 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore ZEVRA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ZEVRA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Thomas D. Anderson | 15,266,761 | -- | -- | 6,062,268 | 9,865,186 | 72% | Not verified | — |
| Elect Director: Neil F. McFarlane | 12,413,828 | -- | -- | 8,915,201 | 9,865,186 | 58% | Not verified | — |
| Elect Director: Alvin Shih, M.D. | 16,592,152 | -- | -- | 4,736,877 | 9,865,186 | 78% | Not verified | — |
| 2. Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company ' s fiscal year ending December 31, 2024 | 22,543,306 | 7,352,086 | 1,298,823 | -- | -- | 75% | Not verified | — |
| 3. Approval, on an advisory and non-binding basis, of the compensation of the Company's named executive officers | 11,167,215 | 9,888,153 | 273,661 | -- | 9,865,186 | 53.0% | Not verified | — |
| 4. Approval of amendments to the Company's Amended and Restated 2014 Equity Incentive Plan | 4,143,728 | 16,964,060 | 221,241 | -- | 9,865,186 | 20% | Not verified | — |
Source: ZEVRA THERAPEUTICS INC., Form 8-K, filed with the SEC on May 13, 2024 — read the filing on EDGAR.
Each item below shows how the 104 asset managers that disclosed a ZEVRA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Alvin Shih, M.D.
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alvin Shih, M.D.”): 16,592,152 for, 4,736,877 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 3 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Neil F. McFarlane
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Neil F. McFarlane”): 12,413,828 for, 8,915,201 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 58% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 3 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Thomas D. Anderson
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Thomas D. Anderson”): 15,266,761 for, 6,062,268 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 2 wordings of this item as funds reported it.
20% Majority: no · of votes cast
Description as filed by funds: To approve amendments to the Company's Amended and Restated 2014 Equity Incentive Plan
ZEVRA THERAPEUTICS INC.’s own tally for this item (“4. Approval of amendments to the Company's Amended and Restated 2014 Equity Incentive Plan”): 4,143,728 for, 16,964,060 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 20% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 1,506,918 | 0 | 0 | Against |
| BlackRock | 0 | 787,245 | 0 | 0 | Against |
| Fidelity | 0 | 400,380 | 0 | 0 | Against |
| TIAA | 0 | 103,941 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 58,825 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 53,925 | 0 | 0 | Against |
| Charles Schwab | 0 | 44,534 | 0 | 0 | Against |
| Lincoln Financial | 0 | 29,400 | 0 | 0 | Against |
| Dimensional | 0 | 24,505 | 0 | 0 | Against |
| Global X | 0 | 19,072 | 0 | 0 | Against |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 17,723 | 0 | 0 | Against |
| John Hancock | 0 | 16,121 | 0 | 0 | Against |
| Northern Trust | 0 | 15,732 | 0 | 0 | Against |
| State Street | 0 | 14,169 | 0 | 0 | Against |
| Pacific Life | 0 | 13,744 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 13,459 | 0 | 0 | Against |
| Voya | 0 | 12,873 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 12,510 | 0 | 0 | Against |
| Equitable | 0 | 9,762 | 0 | 0 | Against |
| Nationwide | 0 | 5,617 | 0 | 0 | Against |
| DWS | 0 | 5,319 | 0 | 0 | Against |
| Victory Capital | 0 | 5,024 | 0 | 0 | Against |
| Principal | 0 | 4,233 | 0 | 0 | Against |
| ProShares | 0 | 4,015 | 0 | 0 | Against |
Fund voting reports, all 33 managers: 3,208,999 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 4 wordings of this item as funds reported it.
53.0% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials
ZEVRA THERAPEUTICS INC.’s own tally for this item (“3. Approval, on an advisory and non-binding basis, of the compensation of the Company's named executive officers”): 11,167,215 for, 9,888,153 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 53.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,187,952 for, 21,047 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Woodline Partners LP | 841,823 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 779,179 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 674,231 | 0 | 0 | 0 | For |
| State Street | 658,134 | 0 | 0 | 0 | For |
| BlackRock | 599,871 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 442,952 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 428,210 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
| Northern Trust | 157,596 | 19 | 0 | 0 | For |
| Wellington | 107,229 | 0 | 0 | 0 | For |
| Nuveen | 103,941 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 99,515 | 0 | 0 | Against |
| Point72 | 92,602 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 65,388 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,525 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 62,229 | 0 | 0 | 0 | For |
| Renaissance | 46,404 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| STRS OHIO | 30,900 | 0 | 0 | 0 | For |
| Rhumbline | 19,778 | 0 | 0 | 0 | For |
| Vanguard | 19,700 | 0 | 0 | 0 | For |
| Goldman Sachs | 54 | 19,354 | 0 | 0 | Against |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 16,116 | 0 | 0 | 0 | For |
Institutional-manager reports, all 84 managers: 5,710,676 for, 151,410 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024
ZEVRA THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company ' s fiscal year ending December 31, 2024”): 22,543,306 for, 7,352,086 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,853,494 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.60% |
| 2 | BlackRock | 1.88% |
| 3 | Fidelity | 0.96% |
| 4 | TIAA | 0.25% |
| 5 | BRIDGEWAY FUNDS INC | 0.14% |
| 6 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| 7 | Charles Schwab | 0.11% |
| 8 | Lincoln Financial | 0.07% |
| 9 | Dimensional | 0.06% |
| 10 | Global X | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Woodline Partners LP | 2.01% |
| 2 | 683 Capital Management, LLC | 1.86% |
| 3 | Janney Montgomery Scott LLC | 1.61% |
| 4 | State Street | 1.57% |
| 5 | BlackRock | 1.43% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.06% |
| 7 | PNC BANK, NATIONAL ASSOCIATION | 1.02% |
| 8 | Altium Capital Management LP | 0.67% |
| 9 | Northern Trust | 0.38% |
| 10 | Wellington | 0.26% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 9.65% | 13F |
| Vanguard Group | 7.37% | 13F |
| Nantahala Capital Management, LLC | 5.86% | DEF14A |
| FMR (Fidelity) | 3.91% | 13F |
| Travis Mickle, Ph.D. | 1.95% | DEF14A |
| Geode Capital | 1.88% | 13F |
| Goldman Sachs | 1.82% | 13F |
| State Street | 1.63% | 13F |
| Morgan Stanley | 1.33% | 13F |
| JPMorgan Chase | 1.05% | 13F |
Percentages above are of 41,853,494 shares outstanding, as reported by ZEVRA THERAPEUTICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ZEVRA THERAPEUTICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.
At ZEVRA THERAPEUTICS INC.'s shareholder meeting held May 13, 2024, in the 2023-2024 proxy season, 104 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 614 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 53.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ZEVRA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2024.
ZEVRA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).
Download data (CSV): ballot items · votes by manager · column guide.